FERMENTA BIOTECH
Back to Balance Sheet
|
FERMENTA BIOTECH Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹209 Cr | ₹245 Cr | ₹194 Cr | ₹230 Cr | ₹228 Cr |
What is the latest Total Current Liabilities ratio of FERMENTA BIOTECH ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹209 Cr |
| Mar2025 | ₹245 Cr |
| Mar2024 | ₹194 Cr |
| Mar2023 | ₹230 Cr |
| Mar2022 | ₹228 Cr |
How is Total Current Liabilities of FERMENTA BIOTECH Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹209 Cr | -14.85 | |
| Mar2025 | ₹245 Cr | 26.34 | |
| Mar2024 | ₹194 Cr | -15.53 | |
| Mar2023 | ₹230 Cr | 0.84 | |
| Mar2022 | ₹228 Cr | - | |
Compare Total Current Liabilities of peers of FERMENTA BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FERMENTA BIOTECH | ₹1,304.9 Cr | -3% | -5.2% | 64.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,803.0 Cr | 0.2% | -5.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 4.9% | -0.5% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,461.0 Cr | -1.1% | -8.5% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 7.8% | 11% | 1.2% | Stock Analytics | |
| CIPLA | ₹109,870.0 Cr | 2.3% | -2.7% | -18.9% | Stock Analytics | |
FERMENTA BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FERMENTA BIOTECH | -3% |
-5.2% |
64.8% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
You may also like the below Video Courses